| David Zeman Md Pc | |
|
29 North Livingston Ave Attn Pob 1967 Livingston NJ 07039-2141 | |
| (973) 953-8580 | |
| Not Available |
| Full Name | David Zeman Md Pc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 29 North Livingston Ave, Livingston, New Jersey |
| Authorized Official Name and Position | David Zeman (PRESIDENT) |
| Authorized Official Contact | 9739538580 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| David Zeman Md Pc 29 North Livingston Ave Attn Pob 1967 Livingston NJ 07039-2141 Ph: (973) 953-8580 | David Zeman Md Pc 29 North Livingston Ave Attn Pob 1967 Livingston NJ 07039-2141 Ph: (973) 953-8580 |
| NPI Number | 1124243118 |
|---|---|
| Provider Enumeration Date | 04/16/2007 |
| Last Update Date | 10/19/2011 |
| Medicare PECOS PAC ID | 7416114376 |
|---|---|
| Medicare Enrollment ID | O20120203000321 |
News Archive
A leading clinical research center in Salt Lake City has joined an international trial program to test an experimental new drug designed to treat painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States. Although not life threatening, dysmenorrhea can be debilitating and psychologically taxing and is one of the leading causes of absenteeism from work and school.
ADVENTRX Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011 for the review of the Exelbine (ANX-530) New Drug Application (NDA).
The heart of healthcare is stressed. With longer shifts, staffing shortages and healthcare changes taxing our nurses, it's no surprise that up to 80 percent report suffering compassion fatigue at some point in their careers, according to recent studies.
DNA editing just got a sharp, new pencil. Researchers have built an enzyme that can perform a previously impossible DNA swap, directly changing the DNA base pair from an A•T to a G•C.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124243118 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 25MA06075000 (New Jersey) | Primary |
| Provider Name | David Zeman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1104049741 PECOS PAC ID: 5294992152 Enrollment ID: I20120214000081 |
News Archive
A leading clinical research center in Salt Lake City has joined an international trial program to test an experimental new drug designed to treat painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States. Although not life threatening, dysmenorrhea can be debilitating and psychologically taxing and is one of the leading causes of absenteeism from work and school.
ADVENTRX Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011 for the review of the Exelbine (ANX-530) New Drug Application (NDA).
The heart of healthcare is stressed. With longer shifts, staffing shortages and healthcare changes taxing our nurses, it's no surprise that up to 80 percent report suffering compassion fatigue at some point in their careers, according to recent studies.
DNA editing just got a sharp, new pencil. Researchers have built an enzyme that can perform a previously impossible DNA swap, directly changing the DNA base pair from an A•T to a G•C.
› Verified 5 days ago
News Archive
A leading clinical research center in Salt Lake City has joined an international trial program to test an experimental new drug designed to treat painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States. Although not life threatening, dysmenorrhea can be debilitating and psychologically taxing and is one of the leading causes of absenteeism from work and school.
ADVENTRX Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011 for the review of the Exelbine (ANX-530) New Drug Application (NDA).
The heart of healthcare is stressed. With longer shifts, staffing shortages and healthcare changes taxing our nurses, it's no surprise that up to 80 percent report suffering compassion fatigue at some point in their careers, according to recent studies.
DNA editing just got a sharp, new pencil. Researchers have built an enzyme that can perform a previously impossible DNA swap, directly changing the DNA base pair from an A•T to a G•C.
› Verified 5 days ago
Mindsoother, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2 W Northfield Rd Ste 211, Livingston, NJ 07039 Phone: 973-220-1885 | |
Essex Health Center Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 11 Mountain Ridge Dr, Livingston, NJ 07039 Phone: 973-266-2905 | |
Online Virtual Counselors Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15 Charles St, Livingston, NJ 07039 Phone: 646-338-5424 | |
John T Miele, Phd Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 301 S Livingston Ave, Suite 202 (acap), Livingston, NJ 07039 Phone: 973-464-9639 | |
Every Piece Counts Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7 Regent St., Suite 708, Livingston, NJ 07039 Phone: 551-237-4646 | |
Ashaworks Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 37 Woodcrest Dr, Livingston, NJ 07039 Phone: 973-207-9273 | |
Better Days Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 301 S Livingston Ave Fl 2, Livingston, NJ 07039 Phone: 973-629-1001 Fax: 973-629-1003 |